,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,68663,3840,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,248,1,1,,68663,3840,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
7,410,1,5,,11113243,3840,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
8,411,2,1,,11113243,3840,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
9,445,3,1,,11113243,3840,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
10,447,1,1,,11113243,3840,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
11,448,1,2,,11113243,3840,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
12,450,1,2,,11113243,3840,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
13,451,1,2,,11113243,3840,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
14,526,1,1,,11113243,3840,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
15,530,1,1,,11113243,3840,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
16,584,1,3,,11113243,3840,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
17,585,1,4,,11113243,3840,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
18,587,1,5,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
19,588,1,4,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
20,589,1,3,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
21,590,1,3,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
22,591,1,4,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
23,592,1,6,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
24,593,1,4,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
25,594,1,4,,11113243,3840,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
26,595,1,3,,11113243,3840,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
27,596,1,2,,11113243,3840,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
28,597,1,3,,11113243,3840,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
29,603,1,2,,11113243,3840,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
30,605,1,2,,11113243,3840,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
31,607,1,3,,11113243,3840,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
32,662,1,1,,11113243,3840,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
33,875,1,2,,26754136,3840,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
34,880,2,1,,26754136,3840,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
35,880,2,1,,26754136,3840,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
36,881,2,2,,26754136,3840,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
37,883,1,3,,11113243,3840,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
38,884,1,2,,26754136,3840,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
39,885,1,2,,26754136,3840,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
40,886,1,2,,11113243,3840,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
41,886,1,2,,11113243,3840,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
42,887,1,2,,26754136,3840,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
43,889,1,3,,26754136,3840,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
44,891,1,2,,11113243,3840,Inconclusive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
45,892,1,2,,26754136,3840,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
46,893,1,2,,26754136,3840,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
47,893,1,2,,26754136,3840,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
48,894,2,1,,26754136,3840,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
49,899,1,2,,11113243,3840,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
50,900,1,3,,26754136,3840,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
51,901,1,2,,26754136,3840,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
52,902,1,2,,26754136,3840,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
53,912,1,2,,11113243,3840,Inconclusive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
54,923,1,2,,26754136,3840,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
55,924,1,2,,26754136,3840,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
56,926,1,2,,11113243,3840,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
57,938,1,2,,11113243,3840,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
58,995,1,2,,26754136,3840,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
59,1030,2,1,,26754136,3840,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
60,1189,1,5,,48413935,3840,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
61,1194,1,3,,48413935,3840,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
62,1199,1,3,,48413935,3840,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
63,1205,1,4,,48413935,3840,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
64,1379,1,2,,26754136,3840,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
65,1452,1,1,,26754136,3840,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
66,1454,1,1,,26754136,3840,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
67,1457,1,1,,26754136,3840,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
68,1460,1,3,,26754136,3840,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
69,1463,1,1,,26754136,3840,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
70,1467,1,3,,26754136,3840,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
71,1468,1,1,,26754136,3840,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
72,1469,1,1,,26754136,3840,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
73,1471,2,1,,11113243,3840,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
74,1471,2,1,,26754136,3840,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
75,1471,2,1,,50125859,3840,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
76,1476,2,1,,26754136,3840,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
77,1477,1,1,,26754136,3840,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
78,1478,2,1,,26754136,3840,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
79,1479,1,2,,26754136,3840,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
80,1490,2,1,,26754136,3840,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
81,1490,2,1,,50125859,3840,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
82,1519,1,3,,26754136,3840,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
83,1580,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
84,1581,1,1,,8150110,3840,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
85,1582,1,1,,8150110,3840,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
86,1583,1,1,,8150110,3840,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
87,1584,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
88,1585,1,1,,8150110,3840,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
89,1586,1,1,,8150110,3840,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
90,1587,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
91,1588,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
92,1589,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
93,1590,1,1,,8150110,3840,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
94,1593,1,1,,8150110,3840,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
95,1594,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
96,1595,1,1,,8150110,3840,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
97,1596,1,1,,8150110,3840,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
98,1597,1,1,,8150110,3840,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
99,1598,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
100,1599,1,1,,8150110,3840,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
101,1600,1,1,,8150110,3840,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
102,1601,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
103,1602,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
104,1603,1,1,,8150110,3840,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
105,1604,1,1,,8150110,3840,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
106,1605,1,1,,8150110,3840,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
107,1606,1,1,,8150110,3840,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
108,1607,1,1,,8150110,3840,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
109,1608,1,1,,8150110,3840,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
110,1609,1,1,,8150110,3840,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
111,1610,1,1,,8150110,3840,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
112,1612,1,1,,8150110,3840,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
113,1613,1,1,,8150110,3840,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
114,1614,1,1,,8150110,3840,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
115,1616,1,1,,8150110,3840,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
116,1688,1,1,,50125859,3840,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
117,1766,1,1,,26754136,3840,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
118,1766,1,1,,26754136,3840,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
119,1766,1,1,,50125859,3840,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
120,1766,1,1,,50125859,3840,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
121,1768,1,1,,26754136,3840,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
122,1768,1,1,,26754136,3840,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
123,1768,1,1,,50125859,3840,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
124,1768,1,1,,50125859,3840,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
125,1865,1,1,,26754136,3840,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
126,1948,1,1,,26754136,3840,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
127,2101,1,1,,26754136,3840,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
128,2107,1,1,,26754136,3840,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
129,2112,1,1,,26754136,3840,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
130,2147,1,1,,26754136,3840,Active,221046486.0,,25.1189,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
131,2451,1,2,,26754136,3840,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
132,2472,1,2,,26754136,3840,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
133,2517,2,1,,26754136,3840,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
134,2528,1,2,,26754136,3840,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
135,2528,1,2,,50125859,3840,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
136,2546,1,1,,26754136,3840,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
137,2546,1,1,,50125859,3840,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
138,2549,1,1,,26754136,3840,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
139,2551,1,1,,26754136,3840,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
140,2551,1,1,,50125859,3840,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
141,72038,4,4,,103193973,3840,Unspecified,,,,,Ability to induce dNTP pool imbalance at 41 uM dose was tested; significant imbalance in the intracellular dNTP pool in FM3A cells,Other,1732542.0,
142,108470,3,5,,103193973,3840,Unspecified,,,,,Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 1 ppm,Other,15125944.0,
143,108471,3,5,,103193973,3840,Unspecified,,,,,Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 10 ppm,Other,15125944.0,
144,108472,3,5,,103193973,3840,Unspecified,,,,,Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 100 ppm,Other,15125944.0,
145,158873,8,1,,103193973,3840,Unspecified,,,1580.0,IC50,In vitro antimalarial activity against Plasmodium falciparum,Confirmatory,7608896.0,
146,174351,3,3,,103193973,3840,Unspecified,,,,,The control period of compound (microg of Fe/h) for biliary excretion of Iron after intravenous administration to the rats,Other,8289206.0,
147,191835,3,3,,103193973,3840,Unspecified,,,,,The treatment period of compound (microg of Fe/h) for biliary excretion of Iron after intravenous administration to the rats,Other,8289206.0,
148,213389,9,3,,103193973,3840,Active,,,22.94,IC50,Compound was evaluated for inhibition of tyrosinase enzyme.,Confirmatory,,
149,215966,9,2,,103193973,3840,Active,,,22.94,IC50,Inhibitory activity against mushroom tyrosinase,Confirmatory,15125944.0,
150,215968,6,4,,103193973,3840,Unspecified,,,280.0,IC50,Inhibitory activity against mushroom tyrosinase (approximate value given),Confirmatory,12824045.0,
151,259214,9,5,,103193973,3840,Active,401235.0,7299.0,16.67,IC50,Inhibitory activity against tyrosinase,Confirmatory,16275084.0,
152,263688,5,8,,103193973,3840,Inactive,401235.0,7299.0,,,Inhibitory activity against tyrosinase at 100uM,Other,16442796.0,
153,263689,3,9,,103193973,3840,Unspecified,401235.0,7299.0,,,Inhibitory activity against tyrosinase at 700uM,Other,16442796.0,
154,264844,8,7,,103193973,3840,Active,6686057.0,,16.3,IC50,Inhibition of mushroom tyrosinase,Confirmatory,16513349.0,
155,276017,3,9,,103193973,3840,Unspecified,401235.0,7299.0,,,Inhibition of tyrosinase at 100 uM,Other,16919455.0,
156,276018,9,5,,103193973,3840,Unspecified,401235.0,7299.0,133.4,IC50,Inhibition of tyrosinase,Confirmatory,16919455.0,
157,292720,6,2,,103193973,3840,Unspecified,,,,,Toxicity in subcutaneously injected NMRI mouse,Other,17049858.0,
158,292721,3,4,,103193973,3840,Unspecified,,,,,"Survival of NMRI mouse for 30 days at 142 mg/kg, sc administered 24 hrs before cobalt 60 gamma irradiation",Other,17049858.0,
159,292722,3,4,,103193973,3840,Unspecified,,,,,"Survival of NMRI mouse for 30 days at 71 mg/kg, sc administered 24 hrs before cobalt 60 gamma irradiation",Other,17049858.0,
160,292725,3,3,,103193973,3840,Active,,,,,Increase in survival of subcutaneously dosed NMRI mouse irradiated with cobalt 60 gamma relative to control,Other,17049858.0,
161,293950,8,7,,103193973,3840,Active,6686057.0,,12.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,17267225.0,
162,294151,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.118 mM,Other,17287127.0,
163,294152,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.047 mM,Other,17287127.0,
164,303545,3,10,,103193973,3840,Active,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as decrease in fluorescence at 0.2 mM,Other,17964155.0,
165,305160,9,5,,103193973,3840,Active,6686057.0,,38.24,IC50,Inhibition of mushroom tyrosinase,Confirmatory,17064896.0,
166,309025,9,5,,103193973,3840,Active,6686057.0,,16.67,IC50,Inhibition of mashroom tyrosinase,Confirmatory,17637486.0,
167,327624,11,2,,103193973,3840,Active,6686057.0,,23.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,18326070.0,
168,331282,9,5,,103193973,3840,Unspecified,6686057.0,,75.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,18501598.0,
169,331284,3,4,,103193973,3840,Unspecified,,,,,Inhibition of melanin production in mouse B16 cells at 1 mM,Other,18501598.0,
170,336442,9,2,,103193973,3840,Unspecified,6686057.0,,235.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,12398542.0,
171,356137,6,4,,103193973,3840,Unspecified,,,125.0,IC50,Inhibition of tyrosinase,Confirmatory,12880321.0,
172,356429,6,4,,103193973,3840,Unspecified,,,125.0,IC50,Inhibition of tyrosinase,Confirmatory,14510598.0,
173,358295,9,5,,103193973,3840,Active,6686057.0,,27.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,11720533.0,
174,383496,7,6,,103193973,3840,Unspecified,6686057.0,,243.0,IC50,Inhibition of Mushroom tyrosinase,Confirmatory,18357995.0,
175,387632,9,5,,103193973,3840,Active,6686057.0,,7.4,IC50,Inhibition of mushroom tyrosinase,Confirmatory,18782667.0,
176,397007,6,3,,103193973,3840,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa PTCC 1074 after 24 hrs by microplate alamar blue assay,Other,19056147.0,
177,397008,6,3,,103193973,3840,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus PTCC 1337 after 24 hrs by microplate alamar blue assay,Other,19056147.0,
178,397011,6,3,,103193973,3840,Unspecified,,,,,Antifungal activity against Candida albicans PTCC 5027 after 48 hrs by microplate alamar blue assay,Other,19056147.0,
179,400520,9,2,,103193973,3840,Unspecified,6686057.0,,250.0,IC50,Inhibition of mushroom tyrosinase by spectrophotometry,Confirmatory,15043425.0,
180,400521,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 333.3 uM/mL by spectrophotometry,Other,15043425.0,
181,400522,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 166.7 uM/mL by spectrophotometry,Other,15043425.0,
182,400523,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 83.3 uM/mL by spectrophotometry,Other,15043425.0,
183,405958,7,6,,103193973,3840,Unspecified,6686057.0,,200.0,IC50,Inhibition of mushroom tyrosinase activity after 10 mins,Confirmatory,18505286.0,
184,410468,9,5,,103193973,3840,Active,6686057.0,,32.3,IC50,Inhibition of mushroom tyrosinase,Confirmatory,19022667.0,
185,410471,3,4,,103193973,3840,Unspecified,,,,,Inhibition of melanin production in mouse B16F10 cells at 200 ug/ml after 72 hrs relative to control,Other,19022667.0,
186,410472,3,4,,103193973,3840,Unspecified,,,,,Inhibition of melanin production in mouse B16F10 cells at 400 ug/ml after 72 hrs relative to control,Other,19022667.0,
187,410475,3,4,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16F10 cells at 200 ug/ml after 72 hrs by MTT assay,Other,19022667.0,
188,410476,3,4,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16F10 cells at 400 ug/ml after 72 hrs by MTT assay,Other,19022667.0,
189,411500,13,2,,103193973,3840,Active,6686057.0,,9.5,IC50,"Inhibition of mushroom tyrosine kinase assessed as oxidation of 0.25 mM L-3,4-dihydroxyphenylalanine",Confirmatory,19054671.0,
190,427670,9,5,,103193973,3840,Unspecified,6686057.0,,132.83,IC50,Inhibition of mushroom tyrosinase activity after 30 mins by spectrophotometry,Confirmatory,19481947.0,
191,427671,9,5,,103193973,3840,Unspecified,6686057.0,,225.14,IC50,Inhibition of mushroom tyrosinase activity after 90 mins by spectrophotometry,Confirmatory,19481947.0,
192,427672,9,5,,103193973,3840,Unspecified,6686057.0,,438.35,IC50,Inhibition of mushroom tyrosinase activity after 150 mins by spectrophotometry,Confirmatory,19481947.0,
193,428332,9,5,,103193973,3840,Unspecified,152060989.0,22173.0,61.0,IC50,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation,Confirmatory,19524439.0,
194,428333,3,10,,103193973,3840,Unspecified,152060989.0,22173.0,,,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation at 100 uM,Other,19524439.0,
195,428334,3,9,,103193973,3840,Unspecified,401235.0,7299.0,,,Inhibition of catecholase activity of tyrosinase in human HMVII cells assessed as dopachrome formation at 100 uM,Other,19524439.0,
196,428335,6,2,,103193973,3840,Unspecified,,,111.0,IC50,Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days,Confirmatory,19524439.0,
197,428337,3,4,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16 cells assessed as cell viability at 200 uM after 2 days by tetrazolium reduction assay,Other,19524439.0,
198,428347,4,7,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as dopachrome formation at 100 uM relative to control,Other,19524439.0,
199,429249,6,2,,103193973,3840,Inconclusive,,,,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma/LPS-stimulated nitric oxide production after 17 to 20 hrs by Griess assay,Confirmatory,19359068.0,
200,429250,6,3,,103193973,3840,Inconclusive,,,,IC50,Antioxidant activity assessed as nitric oxide scavenging activity after 60 min by Griess assay,Confirmatory,19359068.0,
201,429251,6,3,,103193973,3840,Inconclusive,,,,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,19359068.0,
202,429252,9,2,,103193973,3840,Unspecified,,,66.55,IC50,Inhibition of tyrosinase,Confirmatory,19359068.0,
203,436179,6,6,,103193973,3840,Unspecified,6686057.0,,176.0,IC50,Inhibition of mushroom tyrosinase after 30 mins,Confirmatory,18986201.0,
204,436180,6,6,,103193973,3840,Unspecified,6686057.0,,294.0,IC50,Inhibition of mushroom tyrosinase after 90 mins,Confirmatory,18986201.0,
205,440835,3,3,,103193973,3840,Inactive,,,,,Chemical stability at 20 uM at 50 degC after 3 months,Other,19700313.0,
206,440836,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 20 uM by UV spectrophotometry,Other,19700313.0,
207,441043,7,7,,103193973,3840,Unspecified,6686057.0,,,IC50,Inhibition of mushroom tyrosinase assessed as oxidation of L-DOPA,Confirmatory,19700313.0,
208,441044,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as reduction of dopachrome production treated 5 mins before L-tyrosine challenge measured after 10 mins by UV spectrophotometry,Other,19700313.0,
209,441045,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 20 uM after 3 days by UV spectrophotometry,Other,19700313.0,
210,447578,3,4,,103193973,3840,Unspecified,2498443.0,3065.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
211,447578,3,4,,103193973,3840,Unspecified,3334210.0,8841.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
212,447578,3,4,,103193973,3840,Unspecified,19865267.0,9734.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
213,447578,3,4,,103193973,3840,Unspecified,26394832.0,79885.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
214,447578,3,4,,103193973,3840,Unspecified,27734403.0,83933.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
215,447578,3,4,,103193973,3840,Unspecified,29839394.0,55869.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
216,447578,3,4,,103193973,3840,Unspecified,30913097.0,51564.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
217,447578,3,4,,103193973,3840,Unspecified,68068066.0,3066.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
218,447578,3,4,,103193973,3840,Unspecified,205371758.0,10013.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
219,447578,3,4,,103193973,3840,Unspecified,259016348.0,9759.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
220,447578,3,4,,103193973,3840,Unspecified,296434519.0,10014.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
221,450480,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,19615910.0,
222,450481,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,19615910.0,
223,450482,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,19615910.0,
224,450483,8,5,,103193973,3840,Active,6686057.0,,33.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,19615910.0,
225,450493,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 300 uM,Other,19615910.0,
226,450494,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1000 uM,Other,19615910.0,
227,457968,5,2,,103193973,3840,Unspecified,,,70.0,IC50,Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 72 hrs,Confirmatory,20097083.0,
228,460789,5,2,,103193973,3840,Unspecified,,,70.0,IC50,Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 72 hrs,Confirmatory,20044259.0,
229,462346,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,20189399.0,
230,462347,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,20189399.0,
231,462348,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,20189399.0,
232,462349,8,5,,103193973,3840,Active,6686057.0,,30.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,20189399.0,
233,462351,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 300 uM,Other,20189399.0,
234,462352,3,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1000 uM,Other,20189399.0,
235,462366,6,6,,103193973,3840,Unspecified,6686057.0,,250.0,IC50,Inhibition of mushroom tyrosinase assessed as inhibition of melanin production from dopachrome by autoxidation,Confirmatory,20189399.0,
236,467606,6,6,,103193973,3840,Unspecified,6686057.0,,140.0,IC50,Inhibition of mushroom tyrosinase after 10 mins by spectrophotometry,Confirmatory,19555125.0,
237,478539,8,5,,103193973,3840,Active,6686057.0,,16.3,IC50,Inhibition of monophenolase activity of mushroom tyrosinase using as L-tyrosine substrate by spectrophotometric analysis,Confirmatory,20149498.0,
238,478541,5,2,,103193973,3840,Unspecified,,,50.0,IC50,Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 48 hrs,Confirmatory,20149498.0,
239,478728,3,3,,103193973,3840,Active,,,,,Reduction of pigmentation in UV-induced hyperpigmentation brown guinea pig model at 1% applied topically bid for 4 weeks,Other,20149498.0,
240,484880,8,5,,103193973,3840,Active,6686057.0,,9.18,IC50,Inhibition of mushroom tyrosinase preincubated for 5 mins before addition of L-DOPA measured after 10 mins,Confirmatory,20493688.0,
241,485290,1,1,,26754136,3840,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
242,488234,8,5,,103193973,3840,Active,6686057.0,,22.3,Ki,Inhibition of mashroom tyrosinase,Confirmatory,20452224.0,
243,492067,9,5,,103193973,3840,Unspecified,6686057.0,,69.4,IC50,Inhibition of mushroom tyrosinase after 30 mins by spectrophotometric analysis,Confirmatory,20584613.0,
244,492070,4,8,,103193973,3840,Active,401235.0,7299.0,,,Inhibition of tyrosinase in human HEMn-MP assessed as reduction of melanin level at 100 uM after 2 days by spectrophotometric analysis,Other,20584613.0,
245,492967,1,2,,99302011,3840,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
246,493162,1,2,,99302011,3840,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
247,493982,7,5,,103193973,3840,Active,6686057.0,,38.24,IC50,Inhibition of mushroom tyrosinase,Confirmatory,20619644.0,
248,497310,6,1,,103193973,3840,Active,,,6.2,IC50,Inhibition of tyrosinase,Confirmatory,20615711.0,
249,497827,2,3,,103193973,3840,Unspecified,,,,,Protection against fragile X syndrome phenotypes in Fmr1 null mutant Drosophila Fmr1'3/TM6C assessed as embryo viability at 40 uM at 25 degC by flow cytometry relative to untreated homozygous embryos,Other,18327252.0,
250,497831,2,3,,103193973,3840,Unspecified,,,,,Protection against fragile X syndrome phenotypes in laboratory prepared food feeded Fmr1 null mutant Drosophila Fmr1'3/TM6C assessed as homozygous Fmr1-/- embryo viability at 10 uM at 25 degC by flow cytometry relative to untreated homozygous embryos fed with only laboratory prepared food,Other,18327252.0,
251,504749,1,3,,50125859,3840,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
252,504749,1,3,,104171348,3840,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
253,504749,1,3,1.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
254,504749,1,3,2.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
255,504749,1,3,3.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
256,504749,1,3,4.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
257,504749,1,3,5.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
258,504749,1,3,6.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
259,504749,1,3,7.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
260,504749,1,3,8.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
261,504749,1,3,9.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
262,504749,1,3,10.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
263,504749,1,3,11.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
264,504749,1,3,12.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
265,504749,1,3,13.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
266,504749,1,3,14.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
267,504749,1,3,15.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
268,504749,1,3,16.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
269,504749,1,3,17.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
270,504749,1,3,18.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
271,504749,1,3,19.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
272,504749,1,3,20.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
273,504749,1,3,21.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
274,504749,1,3,22.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
275,504749,1,3,23.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
276,504749,1,3,24.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
277,504749,1,3,25.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
278,504749,1,3,26.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
279,504749,1,3,27.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
280,504749,1,3,28.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
281,504749,1,3,29.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
282,504749,1,3,30.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
283,504749,1,3,31.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
284,504749,1,3,32.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
285,504749,1,3,33.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
286,504749,1,3,34.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
287,504749,1,3,35.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
288,504749,1,3,36.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
289,504749,1,3,37.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
290,504749,1,3,38.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
291,504749,1,3,39.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
292,504749,1,3,40.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
293,504749,1,3,41.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
294,504749,1,3,42.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
295,504749,1,3,43.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
296,504749,1,3,44.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
297,504749,1,3,45.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
298,504749,1,3,46.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
299,504749,1,3,47.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
300,504749,1,3,48.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
301,504749,1,3,49.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
302,504749,1,3,50.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
303,504749,1,3,51.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
304,504749,1,3,52.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
305,504749,1,3,53.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
306,504749,1,3,54.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
307,504749,1,3,55.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
308,504749,1,3,56.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
309,504749,1,3,57.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
310,504749,1,3,58.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
311,504749,1,3,59.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
312,504749,1,3,60.0,104171348,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
313,504749,1,3,61.0,50125859,3840,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
314,504832,1,1,,104171348,3840,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
315,504834,1,1,,104171348,3840,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
316,504847,1,1,,104171348,3840,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
317,504865,1,1,,104171348,3840,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
318,517128,9,2,,103193973,3840,Active,6686057.0,,8.33,IC50,Inhibition of mushroom tyrosinase after 10 mins by L-DOPA oxidation assay,Confirmatory,20813526.0,
319,528274,7,5,,103193973,3840,Unspecified,6686057.0,,87.38,IC50,Inhibition of mushroom tyrosinase after 20 mins by microplate reader analysis,Confirmatory,20934336.0,
320,528275,4,2,,103193973,3840,Unspecified,,,89.41,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production treated for 30 mins before LPS challenge measured after 24 hrs by Griess reagent method,Confirmatory,20934336.0,
321,528276,4,2,,103193973,3840,Unspecified,,,100.0,IC50,Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay,Confirmatory,20934336.0,
322,537590,7,5,,103193973,3840,Unspecified,6686057.0,,53.7,IC50,Inhibition of mushroom tyrosinase after 15 mins,Confirmatory,20947360.0,
323,538835,2,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 0.03 mM,Other,21041086.0,
324,538836,2,10,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 0.01 mM,Other,21041086.0,
325,538837,7,5,,103193973,3840,Active,6686057.0,,12.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,21041086.0,
326,566699,3,7,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 mM after 10 mins,Other,21189019.0,
327,566700,3,7,,103193973,3840,Unspecified,126407.0,240.0,,,Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay,Other,21189019.0,
328,566701,3,8,,103193973,3840,Unspecified,50402185.0,,,,Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay,Other,21189019.0,
329,566702,2,9,,103193973,3840,Unspecified,116852.0,4312.0,,,Inhibition of human recombinant MMP1 at 1 mM after 30 mins,Other,21189019.0,
330,566703,3,7,,103193973,3840,Unspecified,116856.0,4313.0,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,Other,21189019.0,
331,566704,2,9,,103193973,3840,Unspecified,116857.0,4314.0,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,Other,21189019.0,
332,566705,3,7,,103193973,3840,Unspecified,116862.0,4317.0,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,Other,21189019.0,
333,566706,3,7,,103193973,3840,Unspecified,269849668.0,4318.0,,,Inhibition of human recombinant MMP9 at 1 mM after 30 mins,Other,21189019.0,
334,566707,3,7,,103193973,3840,Unspecified,266649.0,18126.0,,,Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay,Other,21189019.0,
335,568213,7,5,,103193973,3840,Active,6686057.0,,20.99,IC50,Inhibition of mushroom tyrosinase preincubated for 20 mins,Confirmatory,21256757.0,
336,587205,7,5,,103193973,3840,Active,6686057.0,,10.2,IC50,Inhibition of mushroom tyrosinase preincubated for 10 mins before addition of 1.7 mM L-tyrosine measured after 20 mins by spectrophotometric method,Confirmatory,21226489.0,
337,588379,1,2,,124883017,3840,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
338,588579,1,1,,104171348,3840,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
339,588579,1,1,,124883017,3840,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
340,588834,2,1,,50125859,3840,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
341,589509,6,5,,103193973,3840,Active,6686057.0,,18.45,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as a substrate,Confirmatory,21397499.0,
342,589512,1,11,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 5 uM using L-tyrosine as a substrate,Other,21397499.0,
343,589513,1,11,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1.25 uM using L-tyrosine as a substrate,Other,21397499.0,
344,589514,1,11,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 0.31 uM using L-tyrosine as a substrate,Other,21397499.0,
345,589515,1,11,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 20 uM using L-tyrosine as a substrate,Other,21397499.0,
346,590115,6,2,,103193973,3840,Active,,,7.4,IC50,Inhibition of Tyrosinase,Confirmatory,21334791.0,
347,590195,6,5,,103193973,3840,Unspecified,6686057.0,,51.4,IC50,Inhibition of mushroom tyrosinase after 25 mins by spectrophotometry,Confirmatory,21377874.0,
348,598529,3,2,,103193973,3840,Unspecified,,,70.0,IC50,Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 3 days,Confirmatory,21601449.0,
349,602332,1,1,,104171348,3840,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
350,602332,1,1,,124883017,3840,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
351,610480,4,6,,103193973,3840,Unspecified,6686057.0,,370.0,IC50,Inhibition of mushroom tyrosinase using L-DOPA after 10 mins by ELISA reader,Confirmatory,21500777.0,
352,613824,8,2,,103193973,3840,Unspecified,6686057.0,,102.0,IC50,Inhibition of diphenolase activity of mushroom tyrosinase using L-DOPA as substrate preincubated for 5 mins by spectroscopic method,Confirmatory,21777998.0,
353,624030,1,2,,104171348,3840,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
354,624031,1,2,,104171348,3840,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
355,624032,1,2,,104171348,3840,Active,8393992.0,24660.0,16.1366,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
356,624044,1,2,,104171348,3840,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
357,624170,1,1,,104171348,3840,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
358,624172,1,1,,104171348,3840,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
359,624173,1,3,,104171348,3840,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
360,624296,1,1,,104171348,3840,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
361,624297,1,1,,104171348,3840,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
362,626569,1,8,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate at 10 uM by spectrometric analysis,Other,21978680.0,
363,626570,5,5,,103193973,3840,Unspecified,6686057.0,,70.4,IC50,Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate by spectrometric analysis,Confirmatory,21978680.0,
364,626571,1,4,,103193973,3840,Unspecified,,,,,Inhibition of alpha-MSH -stimulated melanogenesis in mouse B16 cells assessed as melanin release at 10 uM after 72 hrs by spectrometric analysis,Other,21978680.0,
365,626572,3,2,,103193973,3840,Active,,,15.8,IC50,Inhibition of alpha-MSH -stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs by spectrometric analysis,Confirmatory,21978680.0,
366,635123,5,5,,103193973,3840,Unspecified,6686057.0,,69.39,IC50,Inhibition of mushroom tyrosinase activity using L-tyrosin as substrate after 20 mins,Confirmatory,22071299.0,
367,635124,5,2,,103193973,3840,Unspecified,,,1450.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,22071299.0,
368,635125,5,1,,103193973,3840,Unspecified,,,1600.0,IC50,Depigmentation activity in mouse Melan-a cells assessed as inhibition of melanin formation after 4 days,Confirmatory,22071299.0,
369,635126,5,1,,103193973,3840,Unspecified,,,3500.0,IC50,Cytotoxicity against mouse Melan-a cells by modified crystal voilet assay,Confirmatory,22071299.0,
370,639982,3,2,,103193973,3840,Unspecified,,,70.0,IC50,Antimelanogenic activity at alpha-MSH-stimulated mouse melanoma B16 cells after 3 days by spectrophotometry,Confirmatory,22217872.0,
371,646396,5,5,,103193973,3840,Active,6686057.0,,32.62,IC50,Inhibition of mushroom tyrosinase assessed as oxidation of L-dopa by spectrophotometric analysis,Confirmatory,22165973.0,
372,651631,4,1,,144204365,3840,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
373,651631,4,1,,144206999,3840,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
374,651632,4,1,,144204365,3840,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
375,651632,4,1,,144206999,3840,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
376,651633,4,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
377,651633,4,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
378,651634,4,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
379,651634,4,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
380,652048,1,2,,144204365,3840,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
381,652048,1,2,,144206999,3840,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
382,652051,1,1,,144204365,3840,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
383,652051,1,1,,144206999,3840,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
384,654750,2,2,,103193973,3840,Active,,,32.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,22300660.0,
385,654752,2,2,,103193973,3840,Unspecified,,,500.0,IC50,Antimelanogenic activity in mouse B16 cells assessed as inhibition of melanogenesis,Confirmatory,22300660.0,
386,654754,1,3,,103193973,3840,Unspecified,,,,,Cytotoxicity in mouse B16 cells assessed as cell viability at 10 uM after 72 hrs,Other,22300660.0,
387,655298,2,2,,103193973,3840,Active,,,48.52,IC50,Inhibition of mushroom tyrosinase,Confirmatory,22330633.0,
388,655299,2,2,,103193973,3840,Active,,,1.46,IC50,Depigmenting activity in mouse Melan-a cells assessed as melanin production,Confirmatory,22330633.0,
389,655300,1,4,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse Melan-a cells assessed as cell survival at 3 mM,Other,22330633.0,
390,657025,2,2,,103193973,3840,Unspecified,,,,,Inhibition of alpha-MSH-stimulated melanogenesis in mouse B16 cells assessed as melanin release after 72 hrs,Other,22450129.0,
391,662538,2,2,,103193973,3840,Unspecified,,,65.08,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 20 mins by spectrophotometry,Confirmatory,22579419.0,
392,662539,2,2,,103193973,3840,Unspecified,,,187.2,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate after 20 mins by spectrophotometry,Confirmatory,22579419.0,
393,662540,4,1,,103193973,3840,Unspecified,,,1640.0,IC50,Depigmentation activity in mouse Melan-a cells after 4 days by spectrophotometry,Confirmatory,22579419.0,
394,662541,4,1,,103193973,3840,Unspecified,,,3530.0,IC50,Cytotoxicity against mouse Melan-a cells after 4 days by crystal voilet method,Confirmatory,22579419.0,
395,662542,1,2,,103193973,3840,Inconclusive,,,,,Ratio of IC50 for cytotoxicity against mouse Melan-a cells to IC50 for depigmentation in mouse Melan-a cells,Other,22579419.0,
396,670040,1,3,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate at 20 uM after 30 mins by spectrophotometric analysis,Other,22301213.0,
397,670042,2,2,,103193973,3840,Active,,,24.72,IC50,Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate after 30 mins by spectrophotometric analysis,Confirmatory,22301213.0,
398,682404,5,5,,103193973,3840,Active,6686057.0,,16.22,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 5 mins by UV-spectrophotometric analysis,Confirmatory,22901670.0,
399,682406,5,5,,103193973,3840,Active,6686057.0,,15.42,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate after 5 mins by UV-spectrophotometric analysis,Confirmatory,22901670.0,
400,682409,1,8,,103193973,3840,Unspecified,152060989.0,22173.0,,,Inhibition of tyrosinase in mouse B16F10 cells assessed as reduction of melanin production at 200 ug/ml after 72 hrs,Other,22901670.0,
401,682410,1,4,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16F10 cells assessed as cell viability at 200 ug/ml after 76 hrs by MTT assay,Other,22901670.0,
402,686978,1,1,,124883017,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
403,686978,1,1,,144204365,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
404,686978,1,1,,144206999,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
405,686979,1,1,,124883017,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
406,686979,1,1,,144204365,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
407,686979,1,1,,144206999,3840,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
408,687639,2,3,,103193973,3840,Unspecified,,,128.64,IC50,Inhibition of mushroom tyrosinase using as L-tyrosine substrate after 10 mins by spectrophotometric analysis,Confirmatory,21561780.0,
409,687640,2,3,,103193973,3840,Active,,,18.57,IC50,Inhibition of mushroom tyrosinase using as L-DOPA substrate after 2 mins by spectrophotometric analysis,Confirmatory,21561780.0,
410,687649,2,3,,103193973,3840,Active,,,30.0,Ki,Inhibition of mushroom tyrosinase assessed as inhibition constant for compound-free enzyme using as L-tyrosine substrate by spectrophotometric analysis,Confirmatory,21561780.0,
411,687758,2,3,,103193973,3840,Active,,,20.0,Ki,Inhibition of mushroom tyrosinase diphenolase activity,Confirmatory,21561780.0,
412,696879,2,2,,103193973,3840,Active,,,44.6,IC50,Inhibition of tyrosinase using L-dihydroxyphenylalanine as substrate preincubated for 30 mins measured after 7 mins by spectrophotometric analysis,Confirmatory,23113717.0,
413,697856,2,3,,103193973,3840,Unspecified,,,84.54,IC50,Inhibition of alpha-MSH-induced melanogenesis in mouse B16F10 cells after 3 days by spectrophotometric analysis,Confirmatory,23063404.0,
414,715001,2,2,,103193973,3840,Active,,,9.96,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate after 10 mins,Confirmatory,22835872.0,
415,715002,1,2,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 100 ug/ml after 10 mins,Other,22835872.0,
416,720516,2,1,,144204365,3840,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
417,720516,2,1,,144206999,3840,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
418,720532,1,1,,124883017,3840,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
419,720532,1,1,,144204365,3840,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
420,720532,1,1,,144206999,3840,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
421,720533,1,1,,124883017,3840,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
422,720533,1,1,,144204365,3840,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
423,720533,1,1,,144206999,3840,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
424,720552,2,1,,144204365,3840,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
425,720552,2,1,,144206999,3840,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
426,720634,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
427,720634,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
428,720635,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
429,720635,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
430,720637,2,1,,144204365,3840,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
431,720637,2,1,,144206999,3840,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
432,720674,2,2,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
433,720674,2,2,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
434,720675,2,2,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
435,720675,2,2,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
436,720678,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
437,720678,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
438,720679,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
439,720679,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
440,720680,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
441,720680,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
442,720681,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
443,720681,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
444,720682,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
445,720682,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
446,720683,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
447,720683,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
448,720684,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
449,720684,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
450,720685,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
451,720685,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
452,720686,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
453,720686,2,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
454,720687,2,2,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
455,720687,2,2,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
456,720691,4,1,,144204365,3840,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
457,720691,4,1,,144206999,3840,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
458,720692,3,1,,144204365,3840,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
459,720692,3,1,,144206999,3840,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
460,720693,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
461,720693,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
462,720719,2,1,,144204365,3840,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
463,720719,2,1,,144206999,3840,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
464,720725,2,1,,144204365,3840,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
465,720725,2,1,,144206999,3840,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
466,722989,2,1,,103193973,3840,Unspecified,,,,,Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31532 assessed as inhibition of violacein pigment production measured per disk after 48 hrs by NCCLS disk diffusion method,Other,23177728.0,
467,730305,1,2,,103193973,3840,Active,,,18.3,IC50,Inhibition of mushroom tyrosinase assessed as reduction in diphenolase activity using L-DOPA substrate pre-incubated for 20 mins at 30 degC,Confirmatory,23391365.0,
468,740434,1,3,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16F10 cells assessed as cell viability at 200 ug/ml after 72 hrs by micro-culture MTT assay,Other,23411395.0,
469,740436,1,3,,103193973,3840,Unspecified,,,,,Inhibition of melanin production in mouse B16F10 cells at 200 ug/ml after 72 hrs,Other,23411395.0,
470,740438,1,2,,103193973,3840,Active,,,16.67,IC50,Inhibition of diphenolase activity of mushroom tyrosinase assessed as decrease in L-DOPA chrome formation using L-DOPA as substrate preincubated with enzyme for 10 mins prior to substrate addition measured for 10 mins by spectrophotometric assay,Confirmatory,23411395.0,
471,743012,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
472,743012,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
473,743014,3,1,,144204365,3840,Inconclusive,,,13.3332,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
474,743014,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
475,743015,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
476,743015,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
477,743033,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
478,743033,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
479,743035,2,1,,144204365,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
480,743035,2,1,,144206999,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
481,743036,2,1,,144204365,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
482,743036,2,1,,144206999,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
483,743040,3,1,,144204365,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
484,743040,3,1,,144206999,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
485,743041,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
486,743041,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
487,743042,3,1,,144204365,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
488,743042,3,1,,144206999,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
489,743053,2,1,,144204365,3840,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
490,743053,2,1,,144206999,3840,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
491,743054,2,1,,144204365,3840,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
492,743054,2,1,,144206999,3840,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
493,743063,2,1,,144204365,3840,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
494,743063,2,1,,144206999,3840,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
495,743064,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
496,743064,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
497,743065,3,1,,144204365,3840,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
498,743065,3,1,,144206999,3840,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
499,743066,3,1,,144204365,3840,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
500,743066,3,1,,144206999,3840,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
501,743067,2,1,,144204365,3840,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
502,743067,2,1,,144206999,3840,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
503,743069,2,1,,144204365,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
504,743069,2,1,,144206999,3840,Inactive,348019627.0,2099.0,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
505,743074,2,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
506,743074,2,1,,144206999,3840,Inconclusive,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
507,743075,2,1,,144204365,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
508,743075,2,1,,144206999,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
509,743077,2,1,,144204365,3840,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
510,743077,2,1,,144206999,3840,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
511,743078,2,1,,144204365,3840,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
512,743078,2,1,,144206999,3840,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
513,743079,3,1,,144204365,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
514,743079,3,1,,144206999,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
515,743080,3,1,,144204365,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
516,743080,3,1,,144206999,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
517,743081,3,1,,144204365,3840,Inconclusive,,,0.1333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
518,743081,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
519,743083,3,1,,144204365,3840,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
520,743083,3,1,,144206999,3840,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
521,743084,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
522,743084,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
523,743085,3,1,,144204365,3840,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
524,743085,3,1,,144206999,3840,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
525,743086,3,1,,144204365,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
526,743086,3,1,,144206999,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
527,743091,2,1,,144204365,3840,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
528,743091,2,1,,144206999,3840,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
529,743094,3,1,,144204365,3840,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
530,743094,3,1,,144206999,3840,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
531,743122,2,1,,144204365,3840,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
532,743122,2,1,,144206999,3840,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
533,743139,2,1,,144204365,3840,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
534,743139,2,1,,144206999,3840,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
535,743140,2,1,,144204365,3840,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
536,743140,2,1,,144206999,3840,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
537,743191,3,1,,170466814,3840,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
538,743194,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
539,743199,2,1,,170466814,3840,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
540,743202,4,1,,170466814,3840,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
541,743203,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
542,743209,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
543,743210,4,1,,170466814,3840,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
544,743211,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
545,743212,3,1,,170466814,3840,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
546,743213,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
547,743215,3,1,,170466814,3840,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
548,743217,3,1,,170466814,3840,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
549,743218,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
550,743219,3,1,,170466814,3840,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
551,743220,3,1,,170466814,3840,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
552,743221,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
553,743222,3,1,,170466814,3840,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
554,743223,3,1,,170466814,3840,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
555,743224,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
556,743225,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
557,743226,2,1,,170466814,3840,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
558,743227,2,1,,170466814,3840,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
559,743228,3,1,,170466814,3840,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
560,743239,2,1,,170466814,3840,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
561,743240,2,1,,170466814,3840,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
562,743241,2,1,,170466814,3840,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
563,743242,2,1,,170466814,3840,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
564,743244,1,1,,144204365,3840,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
565,743244,1,1,,144206999,3840,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
566,746656,1,1,,103193973,3840,Active,,,14.86,Ki,Competitive inhibition of mushroom tyrosinase diphenolase activity assessed as L-DOPA conversion to dopachrome by Lineweaver-Burk plot analysis,Confirmatory,23566759.0,
567,746658,1,1,,103193973,3840,Active,,,22.5,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins by spectrophotometric analysis,Confirmatory,23566759.0,
568,749862,1,1,,103193973,3840,Active,,,39.0,IC50,Inhibition of melanin production in alpha-MSH stimulated mouse B16 cells after 72 hrs by spectrophotometry,Confirmatory,23623417.0,
569,749863,1,1,,103193973,3840,Inconclusive,,,,IC50,Cytotoxicity against alpha-MSH stimulated mouse B16 cells after 72 hrs by MTT assay,Confirmatory,23623417.0,
570,755116,2,3,,103193973,3840,Active,25453448.0,1610.0,2.0,IC50,Inhibition of human recombinant DAAO expressed in HEK293 cell lysate assessed as D-Serine conversion to H2O2 after 20 mins by spectrophotometric analysis,Confirmatory,23683589.0,
571,755117,2,3,,103193973,3840,Active,129305.0,397134.0,21.0,Ki,Competitive inhibition of pig kidney DAAO using D-Alanine as substrate by Michaelis-Menten plot analysis,Confirmatory,23683589.0,
572,758099,1,1,,103193973,3840,Unspecified,,,53.95,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced after 30 mins by spectrophotometry,Confirmatory,23743286.0,
573,758106,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 50 uM after 30 mins by spectrophotometry,Other,23743286.0,
574,758107,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 40 uM after 30 mins by spectrophotometry,Other,23743286.0,
575,758108,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 30 uM after 30 mins by spectrophotometry,Other,23743286.0,
576,758109,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 20 uM after 30 mins by spectrophotometry,Other,23743286.0,
577,758110,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 10 uM after 30 mins by spectrophotometry,Other,23743286.0,
578,977599,1,1,,103193973,3840,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
579,977602,1,2,,103193973,3840,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
580,1059453,1,1,,103193973,3840,Active,,,46.6,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate preincubated for 10 mins followed by enzyme addition measured after 20 mins by microplate reader analysis,Confirmatory,24268551.0,
581,1061776,1,1,,103193973,3840,Active,,,9.15,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopachrome formation after 5 mins by spectrophotometry,Confirmatory,24332496.0,
582,1064747,1,1,,103193973,3840,Inconclusive,,,,Ki,Competitive inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins with substrate followed by enzyme addition measured after 15 mins by Dixon plot analysis,Confirmatory,24412339.0,
583,1064748,1,1,,103193973,3840,Active,,,37.3,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins with substrate followed by enzyme addition measured after 15 mins by spectrophotometry,Confirmatory,24412339.0,
584,1064749,1,1,,103193973,3840,Inconclusive,,,,Ki,Competitive inhibition of mushroom tyrosinase using L-tyrosine as substrate preincubated for 10 mins with substrate followed by enzyme addition measured after 15 mins by Dixon plot analysis,Confirmatory,24412339.0,
585,1064750,1,1,,103193973,3840,Active,,,12.3,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate preincubated for 10 mins with substrate followed by enzyme addition measured after 15 mins by spectrophotometry,Confirmatory,24412339.0,
586,1082237,1,1,,103193973,3840,Unspecified,,,1000.0,IC50,Inhibition of xanthine oxidase,Confirmatory,21476569.0,
587,1082238,1,4,,103193973,3840,Unspecified,20981678.0,100008601.0,757.0,IC50,Inhibition of Oryctolagus cuniculus (rabbit) AOX in liver cytosol,Confirmatory,21476569.0,
588,1082239,1,1,,103193973,3840,Unspecified,,,93.0,IC50,Inhibition of Agaricus bisporus (mushroom) tyrosinase,Confirmatory,21476569.0,
589,1106459,1,2,,103193973,3840,Unspecified,,,,,Induction of cell cycle arrest in Homo sapiens (human) HeLa cells assessed as accumulation of cells at sub-G1 phase at 25 uM after 24 hr by propidium iodide staining based flow cytometry in presence of 50 uM CuCl2 (Rvb = 3.22%),Other,,
590,1106460,1,3,,103193973,3840,Inconclusive,,,,GI50,Antiproliferative activity against Homo sapiens (human) HeLa cells assessed as growth inhibition after 48 hr by MTT assay in presence of 50 uM CuCl2,Confirmatory,,
591,1106461,1,2,,103193973,3840,Unspecified,,,,,Induction of cell cycle arrest in Homo sapiens (human) HeLa cells assessed as accumulation of cells at sub-G1 phase at 25 uM after 24 hr by propidium iodide staining based flow cytometry (Rvb = 3.41%),Other,,
592,1106464,1,2,,103193973,3840,Inactive,,,,,Antiproliferative activity against Homo sapiens (human) HeLa cells assessed as growth inhibition at 25 uM after 48 hr by MTT assay in presence of 50 uM CuCl2,Other,,
593,1106465,1,2,,103193973,3840,Inactive,,,,,Antiproliferative activity against Homo sapiens (human) HeLa cells assessed as growth inhibition at 25 uM after 48 hr by MTT assay,Other,,
594,1117298,1,2,,170466814,3840,Inactive,,,0.7079,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
595,1117304,1,2,,170466814,3840,Inactive,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
596,1117305,1,2,,170466814,3840,Inactive,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
597,1117310,1,1,,170466814,3840,Inactive,,,0.707946,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
598,1117312,1,1,,170466814,3840,Inactive,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
599,1117314,1,1,,170466814,3840,Inactive,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
600,1117326,1,1,,170466814,3840,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
601,1117329,1,1,,170466814,3840,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
602,1117336,1,1,,170466814,3840,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
603,1117340,1,1,,170466814,3840,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
604,1117341,1,1,,170466814,3840,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
605,1117342,1,1,,170466814,3840,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
606,1117343,1,1,,170466814,3840,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
607,1117346,1,1,,170466814,3840,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
608,1117949,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase assessed as decrease in dopachrome production using L-tyrosine as substrate at 20 uM by spectrophotometric analysis,Other,,
609,1117950,1,1,,103193973,3840,Unspecified,,,,IC50,Inhibition of mushroom tyrosinase assessed as decrease in dopachrome production using L-tyrosine as substrate by spectrophotometric analysis,Confirmatory,,
610,1117951,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase assessed as decrease in dopachrome production using L-tyrosine as substrate at 1.25 uM by spectrophotometric analysis,Other,,
611,1117952,1,1,,103193973,3840,Unspecified,,,,,Inhibition of mushroom tyrosinase assessed as decrease in dopachrome production using L-tyrosine as substrate at 5 uM by spectrophotometric analysis,Other,,
612,1137326,1,1,,103193973,3840,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,423190.0,
613,1139767,1,1,,103193973,3840,Unspecified,,,,,Antimelanogenic activity in mouse B16/F10 cells assessed as inhibition of alpha-MSH-induced melanin formation at 1 mM after 24 hrs by ELISA relative to control,Other,24703463.0,
614,1154176,1,1,,103193973,3840,Active,,,18.25,IC50,Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate assessed as formation of DOPAchrome preincubated for 10 mins followed by substrate addition measured for 1 min,Confirmatory,24857777.0,
615,1155848,2,2,,103193973,3840,Unspecified,152060989.0,22173.0,5500.0,Ki,Inhibition of tyrosinase in mouse Melan-a cells assessed as decrease in L-DOPA Vmax at 120 uM by Lineweaver-Burk plot,Confirmatory,24933607.0,
616,1159509,1,1,,170466814,3840,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
617,1159515,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
618,1159516,1,1,,170466814,3840,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
619,1159517,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
620,1159518,1,1,,170466814,3840,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
621,1159519,1,1,,170466814,3840,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
622,1159520,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
623,1159521,1,1,,170466814,3840,Inactive,15928672.0,19885.0,0.5956,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
624,1159523,1,1,,170466814,3840,Inconclusive,15928672.0,19885.0,3.34915,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
625,1159525,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
626,1159526,1,1,,170466814,3840,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
627,1159527,1,1,,170466814,3840,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
628,1159528,1,1,,170466814,3840,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
629,1159529,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
630,1159531,1,1,,170466814,3840,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
631,1159550,3,1,,252402513,3840,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
632,1159551,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
633,1159552,1,1,,170466814,3840,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
634,1159553,2,1,,170466814,3840,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
635,1159555,1,1,,170466814,3840,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
636,1159580,2,1,,268736467,3840,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
637,1159607,2,1,,312996741,3840,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
638,1159614,1,2,,170466814,3840,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
639,1163967,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 25 ug/ml using L-DOPA as substrate after 2 mins by spectrophotometry,Other,25218909.0,
640,1163968,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 50 ug/ml using L-DOPA as substrate after 2 mins by spectrophotometry,Other,25218909.0,
641,1163969,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 ug/ml using L-DOPA as substrate after 2 mins by spectrophotometry,Other,25218909.0,
642,1163970,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate after 2 mins by spectrophotometry,Other,25218909.0,
643,1167964,1,2,,103193973,3840,Unspecified,6686057.0,,53.7,IC50,Non-competitive inhibition of mushroom tyrosinase,Confirmatory,25288494.0,
644,1167965,1,2,,103193973,3840,Unspecified,401235.0,7299.0,571.17,IC50,Competitive inhibition of tyrosinase in human G-361 cells incubated for 10 mins measured for 2 hrs by MBTH-based spectrophotometry,Confirmatory,25288494.0,
645,1167969,1,1,,103193973,3840,Unspecified,,,,,Ratio of IC50 for tyrosinase in human G-361 cells to IC50 for mushroom tyrosinase,Other,25288494.0,
646,1172562,1,1,,103193973,3840,Unspecified,,,,,Inhibition of melanogenesis in mouse B16F10 cells assessed as reduction in melanin level at 1 mM incubated for 72 hrs,Other,25440886.0,
647,1174113,1,1,,103193973,3840,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate Alamar blue assay,Other,25462220.0,
648,1181357,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 50 uM by spectrophotometry relative to control,Other,24972725.0,
649,1181358,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 50 uM by spectrophotometry relative to control,Other,24972725.0,
650,1181361,1,2,,103193973,3840,Active,6686057.0,,12.6,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate by spectrophotometry,Confirmatory,24972725.0,
651,1181362,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 25 uM by spectrophotometry relative to control,Other,24972725.0,
652,1181365,1,2,,103193973,3840,Active,6686057.0,,32.8,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate by spectrophotometry relative to control,Confirmatory,24972725.0,
653,1181366,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 6.25 uM by spectrophotometry relative to control,Other,24972725.0,
654,1181367,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 12.5 uM by spectrophotometry relative to control,Other,24972725.0,
655,1181368,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 25 uM by spectrophotometry relative to control,Other,24972725.0,
656,1181369,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 6.25 uM by spectrophotometry relative to control,Other,24972725.0,
657,1181370,1,2,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 12.5 uM by spectrophotometry relative to control,Other,24972725.0,
658,1181373,1,2,,103193973,3840,Active,6686057.0,,,,Competitive inhibition of mushroom tyrosinase using L-tyrosine as substrate by Lineweaver-Burk double reciprocal plot method,Other,24972725.0,
659,1181374,1,2,,103193973,3840,Active,6686057.0,,,,Mixed-type inhibition of mushroom tyrosinase using L-tyrosine as substrate by Lineweaver-Burk double reciprocal plot method,Other,24972725.0,
660,1187701,1,2,,103193973,3840,Unspecified,152060989.0,22173.0,,,Inhibition of tyrosinase in mouse B16 cells using L-DOPA as substrate preincubated at 50 uM for 10 mins by spectrophotometry relative to control,Other,25126713.0,
661,1190838,1,2,,103193973,3840,Unspecified,6686057.0,,30.0,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 20 mins by microplate reader,Confirmatory,25597012.0,
662,1190839,1,1,,103193973,3840,Unspecified,,,500.0,IC50,Antimelanogenic activity in mouse B16F10 cells assessed as inhibition of melanin production after 4 days,Confirmatory,25597012.0,
663,1191487,1,2,,103193973,3840,Active,401235.0,7299.0,,,Inhibition of tyrosinase (unknown origin) using L-DOPA as substrate assessed as dopachrome production at 100 uM,Other,25577711.0,
664,1192855,1,2,,103193973,3840,Unspecified,6686057.0,,,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins by spectrophotometry,Confirmatory,25661448.0,
665,1194114,1,2,,103193973,3840,Active,6686057.0,,27.3,IC50,Competitive inhibition of mushroom tyrosinase assessed as inhibition of L-DOPA oxidase activity,Confirmatory,25782744.0,
666,1194115,1,2,,103193973,3840,Active,6686057.0,,8.89,Ki,Competitive inhibition of mushroom tyrosinase assessed as inhibition of L-DOPA oxidase activity at 5 uM active compound by Lineweaver-Burk plot analysis,Confirmatory,25782744.0,
667,1198431,1,2,,103193973,3840,Active,6686057.0,,28.5,IC50,Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate preincubated for 30 mins followed by substrate addition measured for 1 min,Confirmatory,25686594.0,
668,1224834,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
669,1224835,1,1,,170466814,3840,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
670,1224836,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
671,1224837,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
672,1224838,1,1,,170466814,3840,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
673,1224839,1,1,,170466814,3840,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
674,1224840,3,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
675,1224841,3,1,,170466814,3840,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
676,1224842,3,1,,170466814,3840,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
677,1224843,1,1,,170466814,3840,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
678,1224844,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
679,1224845,1,1,,170466814,3840,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
680,1224846,1,1,,170466814,3840,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
681,1224847,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
682,1224848,3,1,,170466814,3840,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
683,1224849,3,1,,170466814,3840,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
684,1224857,2,1,,170466814,3840,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
685,1224859,2,1,,170466814,3840,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
686,1224867,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
687,1224868,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
688,1224869,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
689,1224870,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
690,1224871,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
691,1224872,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
692,1224873,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
693,1224874,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
694,1224875,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
695,1224876,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
696,1224877,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
697,1224878,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
698,1224879,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
699,1224880,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
700,1224881,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
701,1224882,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
702,1224883,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
703,1224884,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
704,1224885,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
705,1224886,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
706,1224887,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
707,1224888,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
708,1224889,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
709,1224890,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
710,1224892,1,1,,170466814,3840,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
711,1224893,1,1,,170466814,3840,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
712,1224894,1,1,,170466814,3840,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
713,1224895,1,1,,170466814,3840,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
714,1224896,1,1,,170466814,3840,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
715,1233232,1,1,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 10 uM after 5 mins by microplate reader analysis relative to control,Other,25987378.0,
716,1233234,1,1,,103193973,3840,Active,6686057.0,,10.0,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production after 5 mins by microplate reader analysis,Confirmatory,25987378.0,
717,1238885,1,1,,103193973,3840,Active,6686057.0,,16.69,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins followed by substrate addition measured after 20 mins,Confirmatory,26204890.0,
718,1247676,1,1,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as reduction in L-DOPA oxidase activity at 50 uM using L-DOPA substrate,Other,26318997.0,
719,1247678,1,1,,103193973,3840,Active,6686057.0,,23.72,IC50,Inhibition of mushroom tyrosinase assessed as reduction in L-DOPA oxidase activity using L-DOPA substrate,Confirmatory,26318997.0,
720,1247679,1,1,,103193973,3840,Active,6686057.0,,11.2,IC50,Inhibition of mushroom tyrosinase assessed as reduction in L-DOPA oxidase activity using L-DOPA substrate at 5 uM by Dixon plot,Confirmatory,26318997.0,
721,1248348,1,1,,103193973,3840,Active,401235.0,7299.0,9.15,IC50,Inhibition of tyrosinase (unknown origin) using L-DOPA as substrate assessed as formation of dopachrome by spectrophotometric analysis,Confirmatory,26386819.0,
722,1253936,1,1,,103193973,3840,Unspecified,,,,,Cytotoxicity against mouse B16F10 cells assessed as cell viability at 200 ug/ml incubated for 72 hrs by MTT assay,Other,26462055.0,
723,1253937,1,1,,103193973,3840,Active,6686057.0,,16.01,IC50,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as formation of L-DOPA chrome preincubated for 10 mins followed by addition of substrate measured over 10 mins by fluorescence assay,Confirmatory,26462055.0,
724,1253939,1,1,,103193973,3840,Unspecified,,,,,Inhibition of tyrosinase in mouse B16F10 cells assessed as reduction of melanin production at 200 ug/ml incubated for 72 hrs,Other,26462055.0,
725,1256363,1,1,,103193973,3840,Active,6686057.0,,23.6,IC50,Inhibition of diphenolase activity of mushroom tyrosinase using L-DOPA as substrate assessed as formation of the DOPA chrome preincubated for 10 mins followed by substrate addition measured for 1 min by spectrophotometric analysis,Confirmatory,26471089.0,
726,1257133,1,1,,103193973,3840,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate at 50 uM,Other,26526213.0,
727,1257134,1,1,,103193973,3840,Active,6686057.0,,27.5,IC50,Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate,Confirmatory,26526213.0,
728,1257138,1,1,,103193973,3840,Active,6686057.0,,12.2,Ki,Competitive inhibition of mushroom tyrosinase polyphenol oxidase activity using L-DOPA as substrate by Dixon plot analysis,Confirmatory,26526213.0,
729,1259241,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
730,1259242,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
731,1259243,1,1,,170466814,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
732,1259244,1,1,,170466814,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
733,1259247,1,1,,170466814,3840,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
734,1259248,1,1,,170466814,3840,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
735,1259344,1,1,,144204365,3840,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
736,1259344,1,1,,144206999,3840,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
737,1259354,1,1,,348406517,3840,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
738,1259355,1,1,,50125859,3840,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
739,1259356,1,1,,144204365,3840,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
740,1259364,1,1,,170466814,3840,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
741,1259365,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
742,1259366,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
743,1259367,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
744,1259368,1,1,,170466814,3840,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
745,1259369,1,1,,170466814,3840,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
746,1259377,1,1,,170466814,3840,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
747,1259378,1,1,,170466814,3840,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
748,1259379,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
749,1259380,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
750,1259381,1,1,,170466814,3840,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
751,1259382,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
752,1259383,1,1,,170466814,3840,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
753,1259384,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
754,1259385,1,1,,170466814,3840,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
755,1259386,1,1,,170466814,3840,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
756,1259387,1,1,,170466814,3840,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
757,1259388,1,1,,170466814,3840,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
758,1259389,1,1,,124636311,3840,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
759,1259390,1,1,,170466814,3840,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
760,1259391,1,1,,170466814,3840,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
761,1259392,1,1,,170466814,3840,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
762,1259393,1,1,,170466814,3840,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
763,1259394,1,1,,170466814,3840,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
764,1259395,1,1,,170466814,3840,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
765,1259396,1,1,,170466814,3840,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
766,1259400,1,1,,124883020,3840,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
767,1259401,1,1,,170466814,3840,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
768,1259402,1,1,,170466814,3840,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
769,1259403,1,1,,170466814,3840,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
770,1259404,1,1,,170466814,3840,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
771,1259407,1,1,,363902081,3840,Active,,,,,CCRIS mutagenicity studies,Other,,
772,1259408,1,1,,363895658,3840,Active,,,,,GENE-TOX mutagenicity studies,Other,,
773,1259410,1,1,,363902081,3840,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
774,1259411,1,1,,363902081,3840,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
775,1259423,1,2,,354914114,3840,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
